These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16837907)

  • 1. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
    Isaikina Y; Shman T
    Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis.
    Choi MR; Kim HY; Park JY; Lee TY; Baik CS; Chai YG; Jung KH; Park KS; Roh W; Kim KS; Kim SH
    Neurosci Lett; 2010 Mar; 472(2):94-8. PubMed ID: 20117176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions.
    Seebach C; Henrich D; Tewksbury R; Wilhelm K; Marzi I
    Calcif Tissue Int; 2007 Apr; 80(4):294-300. PubMed ID: 17431529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
    Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
    Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
    Mareschi K; Ferrero I; Rustichelli D; Aschero S; Gammaitoni L; Aglietta M; Madon E; Fagioli F
    J Cell Biochem; 2006 Mar; 97(4):744-54. PubMed ID: 16229018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bone marrow mesenchymal stem cells in vivo.
    Jones E; McGonagle D
    Rheumatology (Oxford); 2008 Feb; 47(2):126-31. PubMed ID: 17986482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMT504, the prototype of the immunostimulatory oligonucleotides of the PyNTTTTGT class, increases the number of progenitors of mesenchymal stem cells both in vitro and in vivo: potential use in tissue repair therapy.
    Hernando Insúa A; Montaner AD; Rodriguez JM; Elías F; Fló J; López RA; Zorzopulos J; Hofer EL; Chasseing NA
    Stem Cells; 2007 Apr; 25(4):1047-54. PubMed ID: 17420228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of bone marrow endothelial colonies (CFU-En) in non-Hodgkin's lymphoma patients undergoing peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Punturieri M; Moretti S; Dabusti M; Spanedda R; Castoldi G
    Bone Marrow Transplant; 2003 Dec; 32(12):1165-73. PubMed ID: 14647271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors.
    Varas F; Bernard A; Bueren JA
    Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.